← All trials
NCT06492304
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 13, 2024
- Primary completion
- May 31, 2030
- Completion date
- Nov 30, 2030
- First posted
- Jul 9, 2024
- Last posted
- Aug 27, 2024
- Enrollment
- 290
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- CRISPR TherapeuticsLead sponsor
- CRISPR TherapeuticsOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.